Insigneo Advisory Services’s AstraZeneca AZN Stock Holding History

Insigneo Advisory Services’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.12M	Buy	5,754 +1,193	+26%	+$230K	0.08%	200
2025 Q4	$838K	Sell	4,561 -151	-3%	-$26.5K	0.06%	246
2025 Q3	$723K	Buy	4,712 +646	+16%	+$97.8K	0.05%	267
2025 Q2	$568K	Buy	4,066 +25	+0.6%	+$3.5K	0.05%	307
2025 Q1	$594K	Sell	4,041 -20	-0.5%	-$2.89K	0.06%	255
2024 Q4	$532K	Sell	4,061 -840	-17%	-$118K	0.06%	280
2024 Q3	$764K	Buy	4,901 +789	+19%	+$127K	0.08%	216
2024 Q2	$652K	Sell	4,112 -699	-15%	-$105K	0.07%	233
2024 Q1	$652K	Buy	+4,811	New	+$637K	0.08%	212
2023 Q4	–	Sell	-3,581	Closed	-$485K	–	437
2023 Q3	$485K	Buy	3,581 +511	+17%	+$69.8K	0.1%	193
2023 Q2	$439K	Buy	3,070 +69	+2%	+$10.2K	0.08%	220
2023 Q1	$417K	Buy	3,001 +62	+2%	+$8.34K	0.13%	163
2022 Q4	$398K	Buy	+2,939	New	+$369K	0.15%	150

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Insigneo Advisory Services's AZN Position: Q1 2026 in Review

Insigneo Advisory Services increased its AstraZeneca (AZN) stake by 26% in Q1 2026, buying an estimated $230K and bringing the position to 5,754 shares worth $1.12M. The position accounts for 0.08% of the portfolio, ranked #200.

Insigneo Advisory Services first reported a position in AZN in Q4 2022 and has held it in 13 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Insigneo Advisory Services held 5,754 shares of AstraZeneca worth $1.12M as of Q1 2026.
Insigneo Advisory Services bought 1,193 AstraZeneca shares in Q1 2026, an estimated $230K.
AstraZeneca made up 0.08% of Insigneo Advisory Services's portfolio in Q1 2026, its #200 holding.
Insigneo Advisory Services first reported a position in AstraZeneca in Q4 2022 and has held it in 13 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Insigneo Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.